BFM
KURA icon

Boothbay Fund Management’s Kura Oncology KURA Stock Holding History

Boothbay Fund Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-150
Closed -$424K – 1992
2021
Q1 		$424K Sell
150
-151
-50% -$4.78K 0.02% 1024
2020
Q4 		$983K Buy
301
+79
+36% +$2.78K 0.04% 499
2020
Q3 		$680K Buy
+222
New +$4.9K 0.04% 557

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Boothbay Fund Management's KURA Position: Q3 2020 in Review

Boothbay Fund Management sold out of Kura Oncology (KURA) in Q3 2020, closing a stake of 45,656 shares — an estimated $1.01M sold.

Boothbay Fund Management first reported a position in KURA in Q3 2019 and held it in 3 quarters. The position peaked at $854K in Q1 2020. 162 funds tracked by Wall St. Rank hold KURA as of Q3 2020.

  • Boothbay Fund Management reported no remaining Kura Oncology position as of Q3 2020 after selling out during the quarter.
  • Boothbay Fund Management sold 45,656 Kura Oncology shares in Q3 2020, an estimated $1.01M.
  • Boothbay Fund Management first reported a position in Kura Oncology in Q3 2019 and held it in 3 quarters.
  • Boothbay Fund Management's Kura Oncology position peaked at $854K in Q1 2020.
  • 162 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2020.

Based on Boothbay Fund Management's 13F filing for Q3 2020, filed 16 Nov 2020.